Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies
NCT00438178
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Hematological Malignancies
Interventions
DRUG:
Obatoclax mesylate (GX15-070MS)
Sponsor
Gemin X